Mycotic aneurysm caused by gas-forming serotype K5 Klebsiella pneumoniae.
We describe the first documented case of mycotic aneurysm caused by gas-forming serotype K5, and rmpA and iuc positive Klebsiella pneumonia with a hypermucoviscosity phenotype in a diabetic patient. The patient received ceftriaxone for one month and underwent aorto-bi-iliac grafting and inferior mesenteric artery reimplantation and recovered well.
Chen
Yi-Jung
YJ
Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen
Shey-Ying
SY
Wang
Jin-Town
JT
Hsueh
Po-Ren
PR
D000785:Aneurysm, Infected / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000601:surgery; D016667:Bacterial Capsules / Q000378:metabolism*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002443:Ceftriaxone / Q000627:therapeutic use; D048909:Diabetes Complications / Q000382:microbiology*; D005740:Gases / Q000378:metabolism*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology*; D007711:Klebsiella pneumoniae / Q000145:classification* / Q000302:isolation & purification* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012703:Serotyping; D014057:Tomography, X-Ray Computed; D014783:Viscosity
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D005740:Gases; C512267:RmpA protein, Klebsiella pneumoniae; C050673:capsular polysaccharide K5; D002443:Ceftriaxone